The cholinergic dysfunction in AD is characterized by a huge reduction in the neurotransmitter acetylcholine (ACh), and its nicotinic and muscarinic receptors, and by increased ACh-esterase (AChE) and butyrylcholine esterase (BChE) activities [10]. This evidence concerns the gene ACHE and Alzheimer disease.